08:56 AM EDT, 05/21/2024 (MT Newswires) -- Exact Sciences ( EXAS ) said Tuesday it can proceed with its lawsuit against Geneoscopy for patent infringement after a court rejected in part Geneoscopy's motion to dismiss.

The company said it filed the suit in November to stop Geneoscopy from allegedly violating Exact Sciences' ( EXAS ) intellectual property related to its Cologuard colorectal cancer screening test.

Exact Sciences ( EXAS ) filed a new complaint on May 15 alleging another patent infringement against Geneoscopy, the company added.

Geneoscopy did not immediately respond to a request for comment from MT Newswires.

Price: 51.03, Change: +0.03, Percent Change: +0.06